Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human

David A Tipton1, Jon C Flynn, Sidney H Stein

  • 1Department of Periodontology, The University of Tennessee Health Science Center, College of Dentistry, Memphis, TN 38163, USA. dtipton@utmem.edu

Journal of Periodontology
|February 21, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Metal Particles Released during Ultrasonic Scaling of Titanium Surfaces on Human Gingival Fibroblasts.

Journal of long-term effects of medical implants·2022
Same author

Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.

Journal of periodontal research·2022
Same author

Simvastatin loaded chitosan guided bone regeneration membranes stimulate bone healing.

Journal of periodontal research·2021
Same author

Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.

Journal of periodontal research·2020
Same author

The Potential Role of Curcumin in Periodontal Therapy: A Review of the Literature.

Journal of the International Academy of Periodontology·2019
Same author

Vitamin D attenuates human gingival fibroblast inflammatory cytokine production following advanced glycation end product interaction with receptors for AGE.

Journal of periodontal research·2018

Selective COX-2 inhibitors significantly reduced IL-6 production in aggressive periodontitis fibroblasts, suggesting their potential in managing periodontal disease by controlling bone-resorbing cytokines.

Area of Science:

  • Periodontal Medicine
  • Inflammation Biology
  • Pharmacology

Background:

  • Gingival fibroblasts in periodontitis produce the bone-resorbing cytokine IL-6.
  • Prostaglandin E2 (PGE2) regulates IL-6 production.
  • Cyclooxygenase-2 (COX-2) inhibitors may reduce periodontal destruction.

Purpose of the Study:

  • To investigate the effect of COX-2 inhibitors on IL-6 and PGE2 production by IL-1beta-stimulated aggressive periodontitis (AgP) fibroblasts.
  • To understand the role of COX-2 in regulating IL-6 and PGE2 in AgP.

Main Methods:

  • Cultured gingival fibroblasts from healthy and AgP patients.
  • Stimulated cells with IL-1beta and treated with COX inhibitors (indomethacin, NS-398, celecoxib, rofecoxib).
  • Quantified PGE2 and IL-6 levels using ELISA.

Related Experiment Videos

Main Results:

  • All COX inhibitors dose-dependently reduced IL-1beta-stimulated PGE2 (>90%).
  • Selective COX-2 inhibitors partially reduced IL-1beta-stimulated IL-6 (up to ~60%).
  • Adding exogenous PGE2 restored IL-6 levels, indicating PGE2's role in IL-6 regulation.

Conclusions:

  • COX-2 inhibition effectively reduces PGE2 production in AgP fibroblasts.
  • Selective COX-2 inhibitors partially decrease IL-6 production, suggesting a role for COX-2 in IL-6 regulation.
  • COX-2 inhibitors show promise for controlling fibroblast IL-6 production in severe periodontitis.